Dr. William G. Wierda on Role for Ibrutinib in Frontline CLL OncLive 1:38 7 years ago 273 Скачать Далее
Dr. Wierda on Factors to Consider in Frontline Management of CLL OncLive 2:07 7 years ago 233 Скачать Далее
Dr. William Wierda on RESONAT-2 Trial Predictions for Patients With CLL OncLive 1:20 9 years ago 236 Скачать Далее
Adding Venetoclax to Ibrutinib for CLL Patients with High-Risk Disease - Dr. Bill Wierda ASH 2021 CLL Society 7:20 9 months ago 159 Скачать Далее